Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 401
Selected: 0
NCT IDTitle
NCT00003225Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer
NCT00098462Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer
NCT04457245Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer
NCT00039273Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer
NCT02425228Prospective Assessment of Image Registration for the Diagnosis of Prostate Cancer
NCT00104767Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
NCT00096239CP-547,632 in Treating Patients With Recurrent or Persistent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
NCT03953157Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase Inhibitors
NCT04703101Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer
NCT03029481Single Patient Expanded Access to Ganitumab for Metastatic Ewing Sarcoma
NCT03672773Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer
NCT01070186Study of Sunitinib in Subjects With High Risk Renal Cell Carcinoma
NCT01410630FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma
NCT00022334Vaccine Therapy in Treating Patients With Liver Cancer
NCT01051609Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Non-Metastatic, Post Menopausal Breast Cancer Patients
NCT07439484Individually Tailored, Supervised, Remote Exercise Intervention to Improve Physical Function for Stage I-III Gastroesophageal Cancer Survivors, PRECISE Trial
NCT00301990Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
NCT05595499Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors
NCT01029925Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL)
NCT01144247Cellular Immunotherapy Study for Brain Cancer
NCT00685516Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing Surgery
NCT06059690Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
NCT00047255Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer
NCT00761124Informed Decision-Making Regarding Prostate Specific Antigen (PSA) Screening in 50-70 Year Old Latino Men
NCT01574222A Vaccine Trial for Patients With Stage IIIB, IV, or Recurrent Non-Small Cell Lung Cancer
NCT01525264Breast Cancer Screening Intervention
NCT05045027Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma
NCT03596710Image-Guided Biopsies in Identifying Mechanisms of Resistance in Participants With Metastatic Castration Resistant Prostate Cancer Undergoing Radioligand Therapy
NCT00998010Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
NCT00081068Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia
NCT04765150Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
NCT00471887Ticilimumab (CP-675,206) in Treating Patients With Stage IIIC or Stage IV Melanoma
NCT01912820Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery
NCT01351220Community Dissemination of an Evidence-based Colorectal Cancer (CRC) Screening Intervention
NCT00081042ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic Melanoma
NCT04290897Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors
NCT06788938Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine Neoplasms
NCT00020761Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach
NCT00003963Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation
NCT06113016Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors
NCT00087035Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer
NCT01540955Cognitive Rehabilitation Group Intervention for Breast Cancer Survivors
NCT00345826Dasatinib in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia
NCT02092948Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic Cancer
NCT07191717Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial
NCT06064682An Organoid-based Functional Precision Medicine Trial in Osteosarcoma
NCT01664754Exemestane, Pemetrexed Disodium, and Carboplatin in Treating Post-Menopausal Women With Stage IV Non-Small Cell Lung Cancer
NCT02310594Anti-tumor Immune Response in Patients With Cancer Undergoing Radiation Therapy
NCT00021385Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer
NCT05720988Tagraxofusp to Eradicate Measurable Residual Disease in Patients With Acute Myeloid Leukemia